Tech Company Financing Transactions
Athersys Funding Round
Athersys secured a $65 million Private Placement funding round on 6/12/2007. Investors included Radius Ventures, MPM Capital and OrbiMed.
Transaction Overview
Company Name
Announced On
6/12/2007
Transaction Type
Private Placement
Amount
$65,000,000
Round
Private Placement
Investors
Proceeds Purpose
Proceeds from the financing will be used primarily to fund the continued clinical development of Athersys' obesity program, including its lead candidate, ATHX-105, and its non-embryonic stem cell product, MultiStem®, to treat patients for certain cardiovascular disorders, bone marrow transplantation support, and other disease indications, certain pre-clinical development activities, debt repayment, working capital and general corporate purposes.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
3201 Carnegie Ave.
Cleveland, OH 44115
USA
Cleveland, OH 44115
USA
Phone
Website
Email Address
Overview
Athersys, a biopharmaceutical company, discovers and develops therapeutic products for the treatment of several disease indications.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Gil Bokkelen
Chief Operating Officer
William Lehmann
Chief Scientific Officer
John Harrington
Vice President
Robert Mays
Vice President
Anthony Ting
VP - Finance
Laura Campbell
VP - Operations
Raymond Starling
VP - Regulatory Affairs
Manal Morsy
Browse more venture capital transactions:
Prev: 6/12/2007: PayPerPost venture capital transaction
Next: 6/12/2007: OpSource venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs